Middle EAST Spine Biologic Market Competitive Benchmarking and Strategic Outlook
The Middle EAST Spine Biologic Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by a combination of rising incidences of spinal disorders, advancements in surgical techniques, and an increasing preference for minimally invasive procedures. The demand for biologics in spinal surgeries...
0 Commenti 0 condivisioni 5 Views 0 Anteprima